Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10 | 39664 | 42.7 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | AIDS RESEARCH AND HUMAN RETROVIRUSES | journal | 1072433 | 7% | 51% | 2731 |
2 | VIROLOGY | WoSSC | 1034480 | 39% | 9% | 15383 |
3 | HIV 1 | authKW | 869161 | 8% | 37% | 3076 |
4 | JOURNAL OF VIROLOGY | journal | 323299 | 10% | 11% | 4100 |
5 | AIDS | journal | 293165 | 5% | 21% | 1817 |
6 | INFECTIOUS DISEASES | WoSSC | 269035 | 25% | 4% | 9852 |
7 | HIV | authKW | 233779 | 8% | 10% | 3208 |
8 | IMMUNOLOGY | WoSSC | 224565 | 37% | 2% | 14489 |
9 | CCR5 | authKW | 201410 | 1% | 53% | 495 |
10 | VACCINE | address | 158247 | 2% | 29% | 714 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Virology | 1034480 | 39% | 9% | 15383 |
2 | Infectious Diseases | 269035 | 25% | 4% | 9852 |
3 | Immunology | 224565 | 37% | 2% | 14489 |
4 | Microbiology | 15026 | 9% | 1% | 3748 |
5 | Medicine, Research & Experimental | 6642 | 6% | 1% | 2371 |
6 | Biochemistry & Molecular Biology | 2321 | 11% | 0% | 4440 |
7 | Biochemical Research Methods | 2257 | 3% | 0% | 1387 |
8 | Mathematical & Computational Biology | 2188 | 2% | 1% | 666 |
9 | Medicine, General & Internal | 1967 | 5% | 0% | 1995 |
10 | Cell Biology | 1692 | 6% | 0% | 2186 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AIDS | 232130 | 3% | 25% | 1224 |
2 | VACCINE | 158247 | 2% | 29% | 714 |
3 | DUKE HUMAN VACCINE | 103268 | 1% | 63% | 214 |
4 | PARTNERS AIDS | 88535 | 1% | 53% | 219 |
5 | AARON DIAMOND AIDS | 85674 | 1% | 46% | 241 |
6 | RETROVIROL | 85562 | 1% | 36% | 311 |
7 | VIROL | 72818 | 5% | 5% | 1804 |
8 | IAVI NEUTRALIZING ANTIBODY | 70056 | 0% | 89% | 102 |
9 | INFECT DIS | 69723 | 7% | 4% | 2709 |
10 | VIRAL PATHOGENESIS | 67884 | 1% | 43% | 207 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 1072433 | 7% | 51% | 2731 |
2 | JOURNAL OF VIROLOGY | 323299 | 10% | 11% | 4100 |
3 | AIDS | 293165 | 5% | 21% | 1817 |
4 | RETROVIROLOGY | 111997 | 1% | 35% | 422 |
5 | VIROLOGY | 72701 | 3% | 7% | 1342 |
6 | CURRENT OPINION IN HIV AND AIDS | 66581 | 1% | 32% | 269 |
7 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 54613 | 1% | 20% | 354 |
8 | JOURNAL OF INFECTIOUS DISEASES | 50906 | 3% | 6% | 1097 |
9 | JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 46975 | 1% | 12% | 512 |
10 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 44431 | 1% | 25% | 232 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HIV 1 | 869161 | 8% | 37% | 3076 | Search HIV+1 | Search HIV+1 |
2 | HIV | 233779 | 8% | 10% | 3208 | Search HIV | Search HIV |
3 | CCR5 | 201410 | 1% | 53% | 495 | Search CCR5 | Search CCR5 |
4 | GP41 | 155438 | 1% | 80% | 253 | Search GP41 | Search GP41 |
5 | SIV | 150134 | 1% | 51% | 388 | Search SIV | Search SIV |
6 | NEF | 141743 | 1% | 70% | 265 | Search NEF | Search NEF |
7 | HIV 2 | 134413 | 1% | 63% | 279 | Search HIV+2 | Search HIV+2 |
8 | GP120 | 114539 | 1% | 46% | 328 | Search GP120 | Search GP120 |
9 | V3 LOOP | 84216 | 0% | 86% | 127 | Search V3+LOOP | Search V3+LOOP |
10 | HIV VACCINE | 68612 | 0% | 51% | 174 | Search HIV+VACCINE | Search HIV+VACCINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LEVY, JA , (1993) PATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION.MICROBIOLOGICAL REVIEWS. VOL. 57. ISSUE 1. P. 183 -289 | 722 | 61% | 892 |
2 | GIRARD, MP , OSMANOV, S , ASSOSSOU, OM , KIENY, MP , (2011) HUMAN IMMUNODEFICIENCY VIRUS (HIV) IMMUNOPATHOGENESIS AND VACCINE DEVELOPMENT: A REVIEW.VACCINE. VOL. 29. ISSUE 37. P. 6191-6218 | 449 | 80% | 60 |
3 | LEWIS, GK , PAZGIER, M , DEVICO, AL , (2017) SURVIVORS REMORSE: ANTIBODY-MEDIATED PROTECTION AGAINST HIV-1.IMMUNOLOGICAL REVIEWS. VOL. 275. ISSUE 1. P. 271 -284 | 181 | 94% | 2 |
4 | SANDERS, RW , MOORE, JP , (2017) NATIVE-LIKE ENV TRIMERS AS A PLATFORM FOR HIV-1 VACCINE DESIGN.IMMUNOLOGICAL REVIEWS. VOL. 275. ISSUE 1. P. 161 -182 | 177 | 88% | 2 |
5 | DE FEO, CJ , WEISS, CD , (2012) ESCAPE FROM HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) ENTRY INHIBITORS.VIRUSES-BASEL. VOL. 4. ISSUE 12. P. 3859-3911 | 327 | 96% | 10 |
6 | BURTON, DR , HANGARTNER, L , (2016) BROADLY NEUTRALIZING ANTIBODIES TO HIV AND THEIR ROLE IN VACCINE DESIGN.ANNUAL REVIEW OF IMMUNOLOGY, VOL 34. VOL. 34. ISSUE . P. 635 -659 | 149 | 97% | 15 |
7 | MASCOLA, JR , MONTEFIORI, DC , (2010) THE ROLE OF ANTIBODIES IN HIV VACCINES.ANNUAL REVIEW OF IMMUNOLOGY, VOL 28. VOL. 28. ISSUE . P. 413-444 | 210 | 93% | 197 |
8 | ANASTASSOPOULOU, CG , KOSTRIKIS, LG , (2005) VIRAL CORRELATES OF HIV-1 DISEASE.CURRENT HIV RESEARCH. VOL. 3. ISSUE 2. P. 113 -132 | 371 | 88% | 5 |
9 | BERGER, EA , MURPHY, PM , FARBER, JM , (1999) CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: ROLES IN VIRAL ENTRY, TROPISM, AND DISEASE.ANNUAL REVIEW OF IMMUNOLOGY. VOL. 17. ISSUE . P. 657 -700 | 181 | 85% | 1524 |
10 | MASCOLA, JR , HAYNES, BF , (2013) HIV-1 NEUTRALIZING ANTIBODIES: UNDERSTANDING NATURE'S PATHWAYS.IMMUNOLOGICAL REVIEWS. VOL. 254. ISSUE . P. 225-244 | 167 | 93% | 121 |
Classes with closest relation at Level 2 |